Campwala, Insiyah
Guyette, Francis X.
Brown, Joshua B.
Adams, Peter W.
Early, Barbara J.
Yazer, Mark H.
Neal, Matthew D.
Zuckerbraun, Brian S.
Sperry, Jason L. http://orcid.org/0000-0002-7999-8197
Funding for this research was provided by:
Medical Research and Materiel Command (W81XWH-12-2-0023)
Article History
Received: 18 February 2020
Accepted: 17 June 2020
First Online: 1 October 2020
Ethics approval and consent to participate
: This study (STUDY18100001) was approved by the University of Pittsburgh Institutional Review Board (IRB) on 12/13/2018. A letter informing patients of the project was mailed out and provided them the option to opt out of receiving a phone call. A 10-min telephone survey was administered in English and began with an introductory script telling patients and surrogates about the study, its risks and benefits, and asked interviewees to verbally consent to use of questionnaire answers for the project. The introductory script also offered a second opportunity for interviewees to opt out of the study. No incentives for participation were offered.Verbal informed consent was approved by the Institutional Review Board, because this project presented no more than minimal risk of harm to the involved subjects and involved no procedures for which written consent is normally required outside of the research context. Additionally, subjects participated in the project by phone, so obtaining written consent would not have been feasible.
: Not applicable.
: None declared.